Document is current
Any future updates will be listed below
-
Authors
Muddu, Martin
Semitala, Fred C.
Kimera, Isaac
Mbuliro, Mary
Ssennyonjo, Rebecca
Kigozi, Simon P.
Katwesigye, Rodgers
Ayebare, Florence
Namugenyi, Christabellah
Mugabe, Frank
Mutungi, Gerald
Longenecker, Chris T.
Katahoire, Anne R.
Ssinabulya, Isaac
Schwartz, Jeremy I.
-
Funding
Funding for this research was provided by:
Resolve to Save Lives (MJAP/VITAL 2019/001)
Fogarty International Center of the National Institutes of Health (D43 TW010037)
- License Information
-
More Information
Article History
Received: 20 August 2021
Accepted: 5 May 2022
First Online: 25 May 2022
Declarations
:
: All participants provided verbal informed consent to participate in the study since they received integrated hypertension and HIV treatment as part of routine clinical care based on the WHO HEARTS guidelines. Additionally, the medications on our hypertension management protocol were already registered by the National Drug Authority for use in Uganda. The study protocol was approved by The AIDS Support Organization (TASO) Institutional Review Board (IRB) number TASOREC/040/19-UG-REC-009 and the Uganda National Council for Science and Technology (UNCST) number HS 2644.
: Not applicable.
: The authors declare that they have no relevant competing interests.
